Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
PaperCitations, authors & open-access status
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 648 citations, 2016 year and closed oa status.
648
Citations
2016
Year
closed
OA Status